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The classical theory of enzymatic inhibition 
aims to quantitatively describe the effect of 
certain molecules—called inhibitors—on the 
progression of enzymatic reactions, but 
growing signs indicate that it must be revised 
to keep pace with the single-molecule 
revolution that is sweeping through the 
sciences. Here, we take the single enzyme 
perspective and rebuild the theory of 
enzymatic inhibition from the bottom up. We 
find that accounting for multi-
conformational enzyme structure and 
intrinsic randomness cannot undermine the 
validity of classical results in the case of 
competitive inhibition; but that it should 
strongly change our view on the 
uncompetitive and mixed modes of 
inhibition.  There, stochastic fluctuations on 
the single-enzyme level could give rise to 
inhibitor-activator duality—a phenomenon 
in which, under some conditions, the 
introduction of a molecule whose binding 
shuts down enzymatic catalysis will counter 
intuitively work to facilitate product 
formation. We state—in terms of 
experimentally measurable quantities—a 
mathematical condition for the emergence of 
inhibitor-activator duality, and propose that 
it could explain why certain molecules that 
act as inhibitors when substrate 
concentrations are high elicit a non-
monotonic dose response when substrate 
concentrations are low. The fundamental and 
practical implications of our findings are 
thoroughly discussed.  
Enzymes spin the wheel of life by catalyzing a 
myriad of chemical reactions central to the 
growth, development, and metabolism of all 
living organisms1,2. Without enzymes, essential 
processes would progress so slowly that life 
would virtually grind to a halt; and some 
enzymatic reactions are so critical that inhibiting 
them may result in death. Enzymatic inhibitors 
could thus be potent poisons3,4 but could also be 
used as antibiotics5,6 and drugs to treat other 
forms of disease7,8. Inhibitors have additional 
commercial uses9,10, but the fundamental 
principles which govern their interaction with 
enzymes are not always understood in full, and 
have yet ceased to fascinate those interested in 
the basic aspects of enzyme science. The 
canonical description of enzymatic inhibition 
received much exposure1,2,11, but even at the 
level of bulk reactions its many limitations have 
already been pointed out12.  Moreover, and 
despite rapid advancements in the study of 
uninhibited enzymatic reactions on the single-
molecule level, the study of inhibited reactions 
has barely made progress in this direction and is 
still based, by and large, on what is known in 
bulk. 
  
Single molecule approaches revolutionized our 
understanding of enzymatic catalysis13,14. Early 
work demonstrated that at the single molecule 
level enzymatic catalysis is inherently 
stochastic15,16, and that one often needs to go 
beyond the common Markovian description to 
adequately account for the observed 
kinetics17,18,19,20. Universal aspects of stochastic 
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enzyme kinetics, including the widespread 
applicability of the Michaelis–Menten equation 
and its insensitivity to microscopic details, were 
discovered21,22,23,24,25,26,27; and the study of 
enzymatic reactions under force has shed new 
light on the mechanics of the catalytic 
process28,29,30,31,32. 
 
In light of the above, it is somewhat surprising 
that single molecule studies of inhibited 
enzymatic reactions trail behind and are just 
starting to emerge33,34,35,36,37. Specifically, a 
single molecule theory of enzymatic inhibition, 
and in particular one that takes into account 
non-Markovian effects, is still lacking. 
Stochastic, single-molecule, descriptions of 
inhibited enzymatic catalysis can be found, but 
these are oftentimes based on simple kinetic 
schemes that fail to capture the multi-
conformational nature of enzymes, or properly 
account for intrinsic randomness at the 
microscopic level. From a mathematical 
perspective, these kinetic schemes are usually 
built as Markov chains, and while one could 
expand them to account for increased 
complexity this then also compels the 
introduction of many additional parameters. 
These tend to complicate analysis, and also 
make it extremely difficult to discover universal 
principles by generalizing from simple 
examples. Here, we circumvent these problems 
by avoiding the Markov chain formulation to 
develop a non-Markovian theory of enzymatic 
inhibition at the single-enzyme level. 
 
The simplest Markovian description of 
enzymatic inhibition at the single molecule level 
assumes that the completion times of various 
processes involved in the enzymatic reaction 
come from exponential distributions (rates 
depend on process). However, and as discussed 
above, single molecule experiments suggest that 
enzymatic catalysis is often non-Markovian. 
The exponential distribution should then be 
replaced, but the correct underlying distributions 
are usually unknown and guessing them is 
certainly no solution to this problem. Instead, 
we choose not to guess, allowing for catalysis, 
and other, times involved in the reaction to 
come from general, i.e., completely unspecified, 
distributions. This is the central and most 
important difference between our approach and 
the classical one. Rather than first, and often 
wrongly, assuming that all distributions are 
exponential (or come from some other 
prespecified statistics that is dictated by the 
structure of the Markov-chain used), and then 
carrying out the analysis; We show that analysis 
can be carried out even when underlying time 
distributions are treated as unknowns. 
Moreover, since we do not try and guess which 
features of the underlying distributions are 
important, we also do not run into the risk of 
being mistaken in that guess. In other words, 
relevant parameters emerge from our theory as 
output rather than being fed into it as input.   
 
An approach similar to the one described above 
has previously allowed us to revisit the 
fundamentals of uninhibited enzymatic 
reactions, and show that the role of unbinding in 
these must be more complicated than initially 
perceived38. This then facilitated advancements 
in the theory of restarted first-passage-time 
processes39,40,41 as it can be shown that the 
mathematical description of such processes is 
virtually identical to that of enzymatic catalysis 
at the single molecule level. Below, we extend 
our approach to treat inhibited enzymatic 
reactions. Conclusions drawn from our analysis 
are then compared against conventional wisdom 
to predict cases where stochastic fluctuations at 
the level of the single enzyme would inevitably 
lead to a strong departure from the classically 
anticipated behavior.  
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The classical theory of enzymatic inhibition. 
The classical theory of enzymatic inhibition 
considers the effect of molecular inhibitors on 
enzymatic reactions in the bulk, and focuses on 
three canonical modes of inhibition (Fig. 1). In 
this theory, the concentrations of enzyme, 
substrate, inhibitor, and the various complexes 
formed are taken to be continuous quantities and 
differential equations are written to describe 
their evolution in time. Assuming that inhibitor 
molecules can bind either to the free enzyme, E, 
or the enzyme substrate complex, 𝐸𝑆, as in the 
case of mixed inhibition (Fig. 1), and that all 
complexes reach fast equilibrium (the quasi-
steady-state approximation), it can be shown 
that the per enzyme turnover rate, 𝑘𝑡𝑢𝑟𝑛, of an 
inhibited enzymatic reaction obeys11  
 
1
𝑘𝑡𝑢𝑟𝑛
=
𝐾𝑚 (1 +
[𝐼]
𝐾𝐸𝐼
)
𝑣𝑚𝑎𝑥
1
[𝑆]
+
(1 +
[𝐼]
𝐾𝐸𝑆𝐼
)
𝑣𝑚𝑎𝑥
  . 
 
Here, [𝑆] and [𝐼] respectively denote the 
concentrations of substrate and inhibitor, 𝑣𝑚𝑎𝑥 
is the maximal, per enzyme, turnover rate 
attained at an excess of substrate and no 
inhibition, and 𝐾𝑚 is the so-called Michaelis 
constant, i.e., the substrate concentration 
required for the rate of an uninhibited reaction 
to reach half its maximal value. Values for the 
kinetic parameters, 𝐾𝑚 and 𝑣𝑚𝑎𝑥, usually lie in 
the rage of 10−2 − 106𝜇𝑀 and 10−2 − 105𝑠−1, 
respectively42; and in all subsequent examples 
parameters were chosen to comply with these 
typical values.  
 
The parameters  𝐾𝐸𝐼 and 𝐾𝐸𝑆𝐼 denote the 
equilibrium constants related with reversible 
association of the inhibitor to form the 
molecular complexes 𝐸𝐼 and 𝐸𝑆𝐼, respectively. 
In the classical theory, the constants, 𝐾𝑚, 𝐾𝐸𝐼 
and 𝐾𝐸𝑆𝐼 can all be expressed using rates of 
elementary processes (see Fig. 1) to get 𝐾𝑚 =
(𝑘𝑜𝑓𝑓 + 𝑘𝑐𝑎𝑡)/𝑘𝑜𝑛, 𝐾𝐸𝐼 = 𝑘𝑜𝑓𝑓
𝐸𝐼 /𝑘𝑜𝑛
𝐸𝐼 , and 
𝐾ESI = 𝑘𝑜𝑓𝑓
𝐸𝑆𝐼 /𝑘𝑜𝑛
𝐸𝑆𝐼, where 𝑘𝑜𝑛 and 𝑘𝑜𝑓𝑓 are the 
rates at which the substrate binds and unbinds 
the enzyme, and 𝑘𝑜𝑛
𝐸𝐼  (𝑘𝑜𝑛
𝐸𝑆𝐼) and 𝑘𝑜𝑓𝑓
𝐸𝐼  (𝑘𝑜𝑓𝑓
𝐸𝑆𝐼 ) are 
the rates at which the inhibitor binds and 
unbinds the enzyme (enzyme-substrate 
complex). Finally, note that turnover rates for 
the special cases of competitive and 
uncompetitive inhibition can be respectively 
deduced from Eq. (1) by taking the 𝐾ESI → ∞ 
and 𝐾EI → ∞ limits there.  
 
The kinetic schemes described in Fig. 1 also 
serve as a starting point for a single-molecule 
theory of enzymatic inhibition. This theory is 
fundamentally different from the bulk one as it 
aims to describe the stochastic act of a single 
enzyme embedded in a “sea” of substrate and 
inhibitor molecules. However, the main 
observable here is once again the turnover rate, 
𝑘𝑡𝑢𝑟𝑛, which is defined as the mean number of 
product molecules generated by a single enzyme 
per unit time. Equivalently, this rate can also be 
 
Figure 1. The three canonical modes of enzymatic inhibition (from left to right): competitive, uncompetitive and mixed. Rates 
govern transitions between the different states: free enzyme (𝐸), enzyme-substrate complex (𝐸𝑆), enzyme-inhibitor 
complex (𝐸𝐼), enzyme-substrate-inhibitor complex (𝐸𝑆𝐼), and the (𝐸 + 𝑃) state which represents the end of a turnover cycle. 
Competitive Inhibition Uncompetitive Inhibition Mixed Inhibition
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defined as  𝑘𝑡𝑢𝑟𝑛 ≡ 1/〈𝑇𝑡𝑢𝑟𝑛〉,  where the 
average turnover time 〈𝑇𝑡𝑢𝑟𝑛〉 is simply the 
mean time elapsing between successive product 
formation events. Interpreting the kinetic 
schemes in Fig.1 as Markov Chains which 
govern the state-to-state transitions of a single 
enzyme, Eq. (1) can once again be shown to 
hold (SI).  
 
Beyond the classical theory. The kinetic 
schemes presented in Fig. (1) do not account for 
multiple kinetics states which are often part of 
the reaction. For example, it is often necessary 
to discriminate between different enzyme-
substrate complexes, but this could be done in a 
multitude of ways (Fig. 2 left) and the effect of 
inhibition should then be worked out on a case-
by-case basis. This could work well when 
relevant states and transition rates can be 
determined experimentally, but doing so is often 
not possible technically or simply too laborious. 
Indeed, in the overwhelming majority of cases 
the number of kinetic intermediates and the 
manner in which they interconvert is simply 
unknown. There is thus a dire need for a 
description that will effectively take these 
intermediates into account even when 
information about them is partial or completely 
missing. Such description would also be useful 
when trying to generalize lessons learned from 
the analysis of simple case studies of enzymatic 
inhibition. 
  
Generic reaction schemes could be built by 
retaining the same state space as in the classical 
approach (Fig. 1) while replacing the all so 
familiar transition rates with generally 
distributed transition times. This is done in order 
to account for the coarse grained nature of 
states, allowing for a concise description of 
complex reaction schemes. The time it takes to 
complete a transition between two states is then 
characterized by a generic probability density 
function (PDF), e.g., 𝑓𝑇𝑐𝑎𝑡(𝑡) for the catalysis 
time, 𝑇𝑐𝑎𝑡, which governs the transition between 
the ES and E+P states above (Fig. 2 right). 
Applied to all other transitions, an infinitely 
large collection of reactions schemes could then 
be analyzed collectively.  
 
Competitive inhibition at the single-enzyme 
level. To concretely exemplify the approach 
proposed above we consider a generic, not 
 
Figure 3. A generic scheme for competitive inhibition at 
the single enzyme level in which transition rates were 
replaced by generally distributed transition times.  
Figure 2. Kinetic intermediates and multiple reaction 
pathways could complicate the description of a reaction or 
various parts of it. When all intermediates and rates are 
known, these complications could, in principle, be 
addressed on a case by case basis. Alternatively, one 
could account for the non-Markovian nature of transitions 
between coarse grained states by allowing for generally, 
rather than exponentially, distributed transition times. The 
main advantage of this approach is that it allows for 
progress to be made even when the underlying reaction 
schemes are not known in full, i.e., in the absence of 
perfect information. 
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necessarily Markovian, scheme for competitive 
inhibition at the single-enzyme level (Fig. 3). As 
usual in this mode of inhibition, the inhibitor 
can bind reversibly to the enzyme to form an 
enzyme-inhibitor complex which in turn 
prevents substrate binding and product 
formation. However, and in contrast to the 
Markovian approach, here we do not assume 
that the catalysis time 𝑇𝑐𝑎𝑡 is taken from an 
exponential distribution with rate 𝑘𝑐𝑎𝑡, but 
rather let this time come from an arbitrary 
distribution. Since the enzyme is single but the 
substrate and inhibitor are present in Avogadro 
numbers, we assume that the binding times 𝑇𝑜𝑛 
and 𝑇𝑜𝑛
𝐸𝐼 are taken from exponential distributions 
with rates 𝑘𝑜𝑛[𝑆] and 𝑘𝑜𝑛
𝐸𝐼 [𝐼] correspondingly, 
but the distributions of the off times 𝑇𝑜𝑓𝑓 and 
𝑇𝑜𝑓𝑓
𝐸𝐼  are once again left unspecified. We then 
find that the turnover rate of a single enzyme 
obeys (SI) 
 
1
𝑘𝑡𝑢𝑟𝑛
=
𝐾𝑚 (1 +
[𝐼]
𝐾𝐸𝐼
)
𝑣𝑚𝑎𝑥
1
[𝑆]
+
1
𝑣𝑚𝑎𝑥
 . 
 
Note that despite the fact that it is much more 
general, Eq. (2) shows the exact same 
dependencies on the substrate and inhibitor 
concentrations as in the classical theory (Eq. (1) 
in the limit 𝐾ESI → ∞). This result is non-trivial, 
and turns out to hold irrespective of the 
mechanisms which govern the processes of 
catalysis and unbinding. However, and in 
contrast to Eq. (1), the constants 𝐾𝐸𝐼, 𝑣𝑚𝑎𝑥 and  
𝐾𝑚, which enter Eq. (2), can no longer be 
expressed in terms of simple rates, and are 
rather given by (SI): 𝐾𝐸𝐼 = (⟨𝑇𝑜𝑓𝑓
𝐸𝐼 ⟩𝑘𝑜𝑛
𝐸𝐼 )
−1
, 
𝑣𝑚𝑎𝑥 = Pr(𝑇𝑐𝑎𝑡 < 𝑇𝑜𝑓𝑓)/⟨𝑊𝐸𝑆
0 ⟩ and 𝐾𝑚 =
(𝑘𝑜𝑛⟨𝑊𝐸𝑆
0 ⟩)−1. Here,  ⟨𝑇𝑜𝑓𝑓
𝐸𝐼 ⟩ is the mean life 
time of the EI state (inhibitor unbinding time), 
Pr(𝑇𝑐𝑎𝑡 < 𝑇𝑜𝑓𝑓) is the probability that catalysis 
occurs prior to substrate unbinding, and 
⟨𝑊𝐸𝑆
0 ⟩ = ⟨min(𝑇𝑐𝑎𝑡, 𝑇𝑜𝑓𝑓)⟩ is the mean life time 
of the ES state (time spent in that state). 
Concluding, we see that while microscopic 
details of the reaction do enter Eq. (2), they only 
do so to determine various effective constants. 
The functional dependencies of the turnover rate 
on [S] and [I] are insensitive to these details, 
and are in this sense completely universal.  
 
Uncompetitive inhibition at the single-
enzyme level. We now turn to employ the same 
type of analysis to uncompetitive inhibition 
(Fig. 4). Interestingly, the situation here is very 
different form the competitive case analyzed 
above, and strong deviations from the classical 
behavior are observed. To show this, we follow 
a path similar to that taken above and obtain a 
generalized equation for the turnover rate of a 
single enzyme in the presence of uncompetitive 
inhibition (SI) 
   
1
𝑘𝑡𝑢𝑟𝑛
=
𝐾𝑚
𝑣𝑚𝑎𝑥
𝐴([𝐼])
[𝑆]
+
(1 +
[𝐼]
𝐾𝐸𝑆𝐼
)𝐵([𝐼])
𝑣𝑚𝑎𝑥
 , 
 
where 𝐾𝐸𝑆𝐼 = (⟨𝑇𝑜𝑓𝑓
𝐸𝑆𝐼⟩𝑘𝑜𝑛
𝐸𝑆𝐼)
−1
. Equation (3) 
should be compared to Eq. (1) in the limit 
𝐾EI → ∞, and we once again see that both 
exhibit the same characteristic 1/[S] 
dependence. The dependence on inhibitor 
concentration is, however, different from that 
 
Figure 4. A generic scheme for uncompetitive inhibition at 
the single enzyme level. Transition rates were once again 
replaced with generally distributed transition times. 
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in Eq. (1) as Eq. (3) also includes two 
additional factors, 𝐴([𝐼]) and 𝐵([𝐼]), whose 
emergence is a direct result of non-Markovian 
stochastic fluctuations at the single enzyme 
level. 𝐴([𝐼]) and 𝐵([𝐼]) could be understood in 
terms of average life times and transition 
probabilities (Methods), but are otherwise 
complicated functions of [I]. We nevertheless 
note that 𝐴(0) = 𝐵(0) = 1 always; and that in 
the Markovian case, i.e., when the schemes 
presented in Fig. 4 and Fig. 1 (middle) 
coincide, 𝐴([𝐼]) = 𝐵([𝐼]) = 1 for all [I]. 
Equation (3) then reduces to Eq. (1) in the limit 
𝐾EI → ∞, but in all other cases analyzed this is 
no longer true. In particular, Eq. (3) predicts 
that the classical, Markovian, theory of 
uncompetitive inhibition will inevitably break 
down when catalysis times come from a non-
exponential distribution. 
Non-exponential catalysis times lead to a 
breakdown of the classical theory for 
uncompetitive inhibition. To demonstrate the 
breakdown of the classical theory with a simple 
concrete example we will now consider a 
special case of the kinetic scheme illustrated in 
Fig. 4. Namely, we take 𝑓𝑇𝑐𝑎𝑡(𝑡) =
𝑝𝑘𝑐𝑎𝑡
(1) exp(−𝑘𝑐𝑎𝑡
(1)𝑡) + (1 − 𝑝)𝑘𝑐𝑎𝑡
(2) exp(−𝑘𝑐𝑎𝑡
(2) 𝑡),    
with 0 ≤ 𝑝 ≤ 1, for the PDF of the catalysis 
time 𝑇𝑐𝑎𝑡. We thus slightly generalize the 
classical scheme in Fig. 1 (middle) by taking 
𝑓𝑇𝑐𝑎𝑡(𝑡)  to be a mixture of two exponential 
densities (rather than a single exponential), but 
all other transitions times are still taken from   
exponential distributions. This form of 𝑓𝑇𝑐𝑎𝑡(𝑡) 
can be shown to arise when analyzing in detail a 
“two-state” model where the binding of a 
substrate to an enzyme can occur in one of two 
ways, with probabilities 𝑝 and (1 − 𝑝) 
respectively, each leading to a different enzyme 
substrate complex (𝐸𝑆1 or 𝐸𝑆2) equipped with 
a distinct catalytic rate (𝑘𝑐𝑎𝑡
(1)
 or 𝑘𝑐𝑎𝑡
(2)
).  This 
description is equivalent to that given here (SI), 
and we therefore refer to 𝑓𝑇𝑐𝑎𝑡(𝑡) above as that 
associated with the “two state” model.  
Analyzing the two-state model, we find 𝐴([𝐼]) 
and 𝐵([𝐼]) to be monotonically decreasing 
functions of [I] (See Fig. 5A & SI for explicit 
expressions). This is true as long as 𝑘𝑐𝑎𝑡
(1) ≠
𝑘𝑐𝑎𝑡
(2)
 and 0 < 𝑝 < 1, and means that 
𝐴([𝐼]), 𝐵([𝐼]) ≤ 1 for all [I]. When inhibitor 
concentrations are low, these deviations from 
unity are linear in [𝐼]; and for high inhibitor 
concentrations both 𝐴([𝐼]) and 𝐵([𝐼]) 
eventually plateau at a certain level. Since this 
level could be much lower than unity, the 
variation in 𝐴([𝐼]) and 𝐵([𝐼]) may strongly 
affect the turnover rate in Eq. (3). Consider, for 
example, the limit of very high substrate 
concentration and note that we then have 
𝑘𝑡𝑢𝑟𝑛
−1 ([S]  → ∞) ≃ (1 +
[𝐼]
𝐾𝐸𝑆𝐼
)𝐵([𝐼])/𝑣𝑚𝑎𝑥. 
Any deviation from the classical linear relation 
between 𝑘𝑡𝑢𝑟𝑛
−1  and [I] is then because 𝐵([𝐼]) is 
not a constant (Fig. 5b), and could thus be 
interpreted as a measurable telltale sign of non-
Markovian kinetics. 
The most important consequence of the fact that 
non-exponential catalysis times render 𝐴([𝐼]) 
and 𝐵([𝐼]) dependent on inhibitor concentration 
is perhaps the emergence of inhibitor-activator 
duality. This phenomenon is illustrated in Fig. 
5C where we plot the turnover rate from Eq. (3) 
for the two-state model. The classical theory 
predicts that turnover should always decrease 
monotonically with inhibitor concentration, but 
here we find that this is not always the case. 
Specifically, we observe that for certain 
parameter choices (particularly when 𝑘𝑐𝑎𝑡
(1) ≫
𝑘𝑐𝑎𝑡
(2)
, but also when differences between 
catalytic rates are not as drastic) turnover could 
increase with inhibitor concertation in a certain 
concentration range. This non-intuitive behavior 
is most pronounced at low-to-moderate inhibitor  
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Figure 5. A.  In solid blue, 𝐴([𝐼]) and 𝐵([𝐼]) from Eq. (3) for the two-state model (main text). Here, 𝑝 = 0.1, 𝑘𝑐𝑎𝑡
(1) =
50 [𝑚𝑠−1], 𝑘𝑐𝑎𝑡
(2) = 0.5 [𝑚𝑠−1], and all other reaction times are taken from exponential distributions with 𝑘𝑜𝑓𝑓 = 2.3 [𝑚𝑠
−1],
𝑘𝑜𝑛 = 0.1 [(𝜇𝑀 ⋅ 𝑚𝑠)
−1] and 𝑘𝑜𝑛
𝐸𝑆𝐼 = 3 [(𝜇𝑀 ⋅ 𝑚𝑠)−1]. The observed behavior should be compared to that obtained for 𝑘𝑐𝑎𝑡
(1) =
𝑘𝑐𝑎𝑡
(2)
 (dashed green line). The latter case coincides with the classical reaction scheme in Fig. 1 (middle), and gives 𝐴([𝐼]) =
 𝐵([𝐼]) = 1 for all [I]. B. The normalized inverse turnover rate 𝑣𝑚𝑎𝑥𝑘𝑡𝑢𝑟𝑛−1  from Eq. (3) vs. [I] in the limit of saturating substrate 
concentration. As in panel A, the dashed green line is drawn for the degenerate case 𝑘𝑐𝑎𝑡
(1) = 𝑘𝑐𝑎𝑡
(2)
, where 𝐵([𝐼]) = 1, and a 
linear behavior should (and is) observed. In contrast, the solid blue line is drawn for the two-state model with parameters as 
in panel A, and one could clearly observe strong deviations from linearity. This characteristic signature of non-Markovian 
kinetics is directly measurable. C. The turnover rate (normalized by its value in the absence of inhibition) vs. [I] for the two-
state model with three different sets of parameters: (i) 𝑘𝑐𝑎𝑡
(1) = 𝑘𝑐𝑎𝑡
(2) = 0.1 [𝑚𝑠−1] (dashed green); (ii) 𝑘𝑐𝑎𝑡
(1) = 10 [𝑚𝑠−1], 𝑘𝑐𝑎𝑡
(2) =
0.5 [𝑚𝑠−1] (dash-dot orange); and (iii) 𝑘𝑐𝑎𝑡
(1) = 10 [𝑚𝑠−1], 𝑘𝑐𝑎𝑡
(2) = 0.1 [𝑚𝑠−1] (solid blue). In all three cases 𝑝 = 0.1 and other 
parameters are specified in the SI. In sharp contrast to what is predicted by the classical theory, we observe that turnover 
may exhibit a non-monotonic dependence on inhibitor concentration. D. The turnover rate, normalized by its value in the 
absence of inhibition, vs. [I] for three different distributions of the catalysis time: Log-normal (dashed green), Weibull (solid 
blue) and Gamma (dash-dot orange), all with the same mean and variance (see SI for details). The non-monotonic behavior 
of  𝑘𝑡𝑢𝑟𝑛/𝑘𝑡𝑢𝑟𝑛
0  indicates the breakdown of the classical theory.  
 
/
concentrations, and we see that at high inhibitor 
concentrations—where 𝐴([𝐼]) and 𝐵([𝐼]) are 
close to their asymptotic values—normal 
behavior is recovered (increasing inhibitor 
concertation lowers the turnover rate).  
 
Our findings above demonstrate that depending 
on its concentration, and the inner workings of 
the enzyme, a molecule could act either as an 
inhibitor or as an activator—despite the fact that 
its binding always results in utter and complete 
shutdown of enzymatic catalysis. One way to 
understand this, still within the framework of 
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the two-state model, is to realize that while the 
binding of such a molecule prevents product 
formation, it could also act as an effective 
switch between fast and slow catalytic states 
when these exist. Consider, for example, a 
scenario where one catalytic state is 
characterized by a rate that is much higher than 
that of the other (𝑘𝑐𝑎𝑡
(1) ≫ 𝑘𝑐𝑎𝑡
(2)
). This time scale 
separation allows for a scenario where inhibitor 
binding is not frequent enough to interrupt 
catalysis when it proceeds through the fast 
catalytic pathway (hence the need for low to 
moderate inhibitor concentrations), but frequent 
enough so as to stop catalysis when it proceeds 
through the slow catalytic pathway. After the 
inhibitor unbinds, the enzyme could return to 
either of the catalytic states, potentially 
switching from slow to fast. This type of 
inhibitor-induced switching greatly facilitates 
turnover.  
 
The emergence of inhibitor-activator duality is 
not unique to the two-state model, but rather a 
generic phenomenon whose origin we trace to 
stochastic fluctuations at the single enzyme 
level. Depending on the enzyme, its 
conformations and the way they interconvert, a 
multitude of catalysis time distributions may 
arise. However, since these stem from multiple 
transitions between enzymatic states, the 
resulting catalysis time distributions would 
always be non-exponential and render 
𝐴([𝐼]) and 𝐵([𝐼]) inhibitor concentration 
dependent. This would in turn lead to the 
breakdown of the classical theory. To 
demonstrate this, we plot the turnover rate from 
Eq. (3) for catalysis time distributions other than 
the one considered so far (Fig. 5D). In all cases, 
we find that within a certain concertation range 
the presence of an uncompetitive “inhibitor” 
surprisingly acts to facilitate enzymatic activity. 
Numerical simulations further support these 
conclusions (SI). 
 
A general criterion for the emergence of 
inhibitor-activator duality. The net effect 
resulting from the presence of an uncompetitive 
inhibitor also depends on substrate 
concentration as is demonstrated in Figs. 6A & 
6B where we dissect the {[I],1/[S]} plane into 
three, qualitatively distinct, phases. As before, 
we use the two-state model to illustrate that as 
inhibitor concentrations increase an activator-
inhibitor transition may take place. However, it 
can now be seen that even within this simple, 
two-state, toy model the manner in which the 
activator-inhibitor transition unfolds depends on 
the concentration of the substrate (Fig. 6A). 
Moreover, in some cases a transition does not 
occur at all, or only occurs when substrate 
concentrations are low enough (Figs. 6B & 6C). 
Therefore, a general criterion for the emergence 
of inhibitor-activator duality is required.    
 
Enzymatic reactions may involve many 
intermediate states and reaction pathways, and 
these could be different, or markedly more 
complex, than the two-state model we have 
analyzed above for illustration purposes. This 
bedazzling variety that enzymes display seems 
to hinder further progress as additional case 
studies usually need to be analyzed one at a 
time. However, the approach developed herein 
allows us to treat an infinite collection of 
reaction schemes in a joint and unified manner 
to determine the effect resulting from the 
introduction of an uncompetitive inhibitor. 
Analyzing the generic reaction scheme in Fig. 4, 
we find that a general criterion asserting the 
emergence of inhibitor-activator duality (i.e., 
asserting that 𝑑𝑘𝑡𝑢𝑟𝑛/𝑑[𝐼]|[𝐼]=0 > 0) can be 
written in terms of experimentally measurable 
quantities (Methods). A slightly simplified 
version of this criterion is discussed below. 
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Figure 6. A & B. Phase diagrammatic representation of 
enzymatic turnover for two different instances of the two-
state model. Here, activation is the phase where turnover is 
higher than its value in the absence of inhibition (i.e., when 
[I]=0), and any increase in inhibitor concentration increases 
turnover further; transition is the phase where turnover is 
still higher than its value in the absence of inhibition, but 
where further increase in inhibitor concentration results in a 
decrease of the turnover rate; and inhibition is the phase 
where turnover is lower than its value in the absence of 
inhibition, and any increase in inhibitor concentration 
decreases turnover further still. Keeping substrate 
concentration fixed, and varying the concentration of the 
inhibitor, turnover attains a maximum when crossing the 
line which separates the activation and transition phases, 
and re-attains its value at [I]=0 when crossing the line 
which separates the transition and inhibition phases. Plots 
were made with the following parameters: 𝑘𝑐𝑎𝑡
(1) =
50 [𝑚𝑠−1], 𝑘𝑐𝑎𝑡
(2) = 0.5 [𝑚𝑠−1], 𝑝 = 0.1, 𝑘𝑜𝑛 = 0.2 [(𝜇𝑀 ⋅
𝑚𝑠)−1],  𝑘𝑜𝑛
𝐸𝑆𝐼 = 30 [(𝜇𝑀 ⋅ 𝑚𝑠)−1],  𝑘𝑜𝑓𝑓
𝐸𝑆𝐼 = 50[𝑚𝑠−1] and two 
different values of 𝑘𝑜𝑓𝑓 (indicated in the top left corner of 
each panel).  
C. Lateral cross-sections through panel B showing the turnover rate, normalized by its value in the absence of inhibition, as 
a function of [I]. The activation phase in panel B corresponds to the ascending branch of the curves in panel C, whereas the 
transition and inhibition phases correspond to the part of the descending branch of the curves which respectively lies above, 
and below, unity. Substrate concentrations, corresponding to where cross-sections in panel B were taken, are indicated next 
to each curve. 
/
When substrate binding and unbinding are 
Markovian processes with rates 𝑘𝑜𝑛[𝑆] and 𝑘𝑜𝑓𝑓 
respectively, but with inhibitor unbinding and 
catalysis times still allowed to come from 
arbitrarily distributions, we find that inhibitor-
activator duality will be observed whenever 
(Methods, SI)  
 
⟨𝑇𝑜𝑓𝑓
𝐸𝑆𝐼⟩ <
1
2
[𝐶𝑉
𝑊𝐸𝑆
0
2 − 1]
1
𝑣𝑚𝑎𝑥
[1 +
𝑘𝑜𝑓𝑓
𝑘𝑜𝑛[𝑆]
] .  
Here, ⟨𝑇𝑜𝑓𝑓
𝐸𝑆𝐼⟩, which stands on the left-hand side 
for the mean life time of the ESI complex, is the 
only quantity in this inequality that relates to the 
kinetics of the inhibited enzyme. On the right-
hand side, 𝐶𝑉𝑊𝐸𝑆0  stands for the coefficient of 
variation (standard deviation over mean) 
associated with the stochastic life time of the ES 
complex in the absence of inhibition, and all 
other quantities are defined as they were 
10 
 
(5) 
 
fsg 
immediately after Eq. 2. And so, despite the 
infinitely many degrees of freedom we have 
allowed for by leaving the distributions of 
inhibitor unbinding and catalysis times 
unspecified, predictions coming from our theory 
could still be tested on any enzyme of interest 
simply by measuring means and variances 
(rather than full distributions) of certain 
stochastic times associated with the reaction at 
the single enzyme level. This important feature 
of our theory carries over to the more general 
condition for the emergence of inhibitor-
activator duality (Methods).     
 
It should be noted that the criterion in Eq. (4) 
can only be fulfilled when 𝐶𝑉𝑊𝐸𝑆0 > 1 since 
⟨𝑇𝑜𝑓𝑓
𝐸𝑆𝐼⟩ is always positive. The coefficient of 
variation 𝐶𝑉𝑊𝐸𝑆0  is a dimensionless measure for 
the dispersion of the distribution governing the 
stochastic life time of the ES state in the absence 
of inhibition. The more dispersed (wide) this 
distribution is the larger 𝐶𝑉𝑊𝐸𝑆0  and vice versa. 
In the classical theory, the Markovian 
formulation implies that time spent at the ES 
state is exponentially distributed (SI). This 
means that the standard deviation and mean of 
this time are equal, i.e., that 𝐶𝑉𝑊𝐸𝑆0 = 1. In this 
case, and whenever the life time distribution is 
narrower than the exponential, inhibitor 
activator duality will not be observed. Broader 
life time distributions with 𝐶𝑉𝑊𝐸𝑆0 > 1 are 
expected for enzymes with alternative kinetic 
pathways19,25; and the condition in Eq. (4) will 
then hold as long as substrate concentrations are 
low enough. Moreover, if ⟨𝑇𝑜𝑓𝑓
𝐸𝑆𝐼⟩𝑣𝑚𝑎𝑥 <
1
2
[𝐶𝑉
𝑊𝐸𝑆
0
2 − 1], inhibitor activator duality will be 
observed regardless of substrate concentration. 
 
Mixed inhibition at the single-enzyme level. 
Before concluding, we note that the mixed mode 
of inhibition is subject to the same type of 
analysis applied above. In this case we find (SI)  
 
1
𝑘𝑡𝑢𝑟𝑛
=
𝐾𝑚 (1 +
[𝐼]
𝐾𝐸𝐼
)
𝑣𝑚𝑎𝑥
A([I])
[𝑆]
+
(1 +
[𝐼]
𝐾𝐸𝑆𝐼
)𝐵([𝐼])
𝑣𝑚𝑎𝑥
 , 
 
and a criterion analogous to Eqs. (4) and (M6) 
in methods is also obtained (SI). In fact, all of 
the results in this paper could be derived by 
starting with Eq. (5) (SI), which generalizes and 
replaces Eq. (1) to describe enzymatic inhibition 
at the single-enzyme level. Specifically, note 
that the structure of Eq. (5), and that of Eqs. (2) 
& (3) as special cases, casts doubt on the ability 
of classical methods, e.g., that of Lineweaver & 
Burk43, to reliably discriminate between 
different modes of enzymatic inhibition, and 
suggests that these methods be revised. Finally, 
we note that while the framework considered 
herein allows for arbitrary, rather than 
exponentially, distributed transition times 
between kinetic states, it still retains the 
common assumption (also used in the stochastic 
derivation of Eq. (1)) that the system “forgets” 
the state of origin after leaving it44. Accounting 
for memory of past states could be important in 
certain cases, but the incorporation of a general 
form of such memory into the framework 
presented herein currently seems to be out of 
reach. Progress in this direction is an important 
future challenge and is anticipated to advance 
both theory and practice.   
 
Conclusions & Outlook. How would the 
average rate at which an enzyme converts 
substrate into product change in the presence of 
a molecule whose binding to the enzyme 
completely shuts down its ability to catalyze? As 
we have shown, the answer to this question is 
not as simple and straightforward as it seems 
and curiously depends on the mode of 
inhibition, the molecular inner workings of the 
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enzyme, and on a delicate interplay between 
substrate and inhibitor concentrations. The 
classical theory of inhibition provides no clue to 
this, but the single-enzyme approach taken 
herein shows that there are cases where the 
presence of a molecule could result in an 
increase of the turnover rate — even though its 
binding to the enzyme always results in utter 
and complete shutdown of enzymatic catalysis. 
Notably, this is not because some conformations 
of the enzyme-inhibitor complex are inhibitory 
and others excitatory or due to an interaction 
with some additional molecule/s45,46 (also see 
“inhibition paradox”12), but rather because 
catalysis in the absence of any external modifier 
is non-Markovian. In other words, multiple 
enzyme conformations result in non-exponential 
transitions between coarse grained “states” and 
this, surprisingly, is already enough to produce 
the effect. This surprising finding not only 
exposes fundamental flaws in our current 
understanding of enzymatic inhibition, but also 
has direct practical implications as inhibitors are 
in widespread commercial use.  
 
Take for example DAPT (N-[N-(3,5-
difluorophenacetyl)-L-alanyl]-S-phenylglycine 
t-butyl ester), a compound tested and verified to 
act as an inhibitor of the enzyme γ-secretase. 
Developed and researched for over a decade, 
this once promising treatment of Alzheimer’s 
disease was eventually abandoned as it was 
discovered that when administered at low 
concentrations, and when substrate 
concentrations were also low, it acted as an 
activator47,48,49,50. More awareness to the issue 
of inhibitor-activator duality would have surely 
resulted in earlier discovery of this biphasic 
response, saving precious time, money, and 
human effort.  
 
Additional examples where inhibitor-activator 
duality was experimentally observed include the 
effects of such drugs as valinomycin, SL-
verapamil and colchicine on Pgp ATPase 
activity51,52, and the effect of ADP on ATP 
hydrolysis by GroEL53. As in the case of DAPT, 
the qualitative nature of the phenomenon and its 
features are similar to those predicted by our 
theory, but lack of single-molecule 
measurements prevents us from unambiguously 
concluding that the mechanism we describe is 
indeed the one at play. Regardless, we have 
hereby shown that inhibitor-activator duality is 
inherent to the uncompetitive and mixed modes 
of inhibition, and that it is expected to naturally 
arise due to stochastic fluctuations occurring at 
the level of the single enzyme. Equation (4) and 
its generalizations then suggest that, if sought 
for, the effect could be observed in enzymes 
exhibiting multi-conformational, non-
Markovian, kinetics from the kind that has 
already been documented in the past17,18,19. 
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Methods.  
 
I. Definition of 𝑨([𝑰]) and 𝑩([𝑰]) in Eqs. (3) 
and (5). 𝐴([𝐼]) and 𝐵([𝐼]) are defined using 
two auxiliary functions  
 
𝑓𝑀(𝑠) = ∫ 𝑒
−𝑠𝑡𝐾𝑚𝑘𝑜𝑛
∞
0
?̅?𝑇𝑐𝑎𝑡(𝑡)?̅?𝑇𝑜𝑓𝑓(𝑡)𝑑𝑡 ,  
 
and  
 
𝑓𝑃(𝑠) = ∫ 𝑒
−𝑠𝑡 𝐾𝑚𝑘𝑜𝑛
𝑣𝑚𝑎𝑥
∞
0
𝑓𝑇𝑐𝑎𝑡(𝑡)?̅?𝑇𝑜𝑓𝑓(𝑡)𝑑𝑡 . 
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Here, 𝐾𝑚, 𝑘𝑜𝑛 , and 𝑣𝑚𝑎𝑥  are defined as they 
were right after Eq. (2) in the main text, 
?̅?𝑇𝑐𝑎𝑡(𝑡) = ∫ 𝑓𝑇𝑐𝑎𝑡(𝑡)
∞
𝑡
𝑑𝑡 , and ?̅?𝑇𝑜𝑓𝑓(𝑡) =
∫ 𝑓𝑇𝑜𝑓𝑓(𝑡)
∞
𝑡
𝑑𝑡. It can then be shown that (SI)  
 
𝐴([𝐼]) =
1−
𝑘𝑜𝑛
𝐸𝑆𝐼[𝐼]
𝐾𝑚𝑘𝑜𝑛
?̃?𝑀(𝑘𝑜𝑛
𝐸𝑆𝐼[𝐼])
?̃?𝑃(𝑘𝑜𝑛
𝐸𝑆𝐼[𝐼])
=
1−⟨𝑊𝐸𝑆⟩/⟨𝑇𝑜𝑛
𝐸𝑆𝐼⟩
Pr(𝑇𝑐𝑎𝑡<𝑇𝑜𝑓𝑓,𝑇𝑜𝑛
𝐸𝑆𝐼)/Pr(𝑇𝑐𝑎𝑡<𝑇𝑜𝑓𝑓)
 , 
and  
 
 𝐵([𝐼]) =
?̃?𝑀(𝑘𝑜𝑛
𝐸𝑆𝐼[𝐼])
?̃?𝑃(𝑘𝑜𝑛
𝐸𝑆𝐼[𝐼])
=
⟨𝑊𝐸𝑆⟩Pr(𝑇𝑐𝑎𝑡<𝑇𝑜𝑓𝑓)
⟨𝑊𝐸𝑆
0 ⟩Pr(𝑇𝑐𝑎𝑡<𝑇𝑜𝑓𝑓,𝑇𝑜𝑛
𝐸𝑆𝐼)
 , 
 
where ⟨𝑊𝐸𝑆
0 ⟩ = ⟨min(𝑇𝑐𝑎𝑡, 𝑇𝑜𝑓𝑓)⟩ and ⟨𝑊𝐸𝑆⟩ =
⟨min(𝑇𝑐𝑎𝑡, 𝑇𝑜𝑓𝑓, 𝑇𝑜𝑛
𝐸𝑆𝐼)⟩  are correspondingly the 
mean life times of the ES complex with and 
without inhibition, and Pr(… )  denotes the 
probability for the occurrence of a specified 
event.  
II. Probabilistic derivation of a general 
criterion for the emergence of inhibitor-
activator duality and of Eq. (4). When will the 
introduction of an uncompetitive inhibitor 
increase the turnover rate? Consider the 
difference between a scenario where inhibitor 
molecules are not present, and a scenario where 
they are present at exceedingly low 
concentrations. Any interaction between the ES 
complex and an inhibitor molecule would then 
be very rare but will eventually happen at some 
point in time. In what follows, we try to 
determine what will be the effect this interaction 
has on the average time taken to compete an 
enzymatic reaction cycle.  
 
An ESI complex will be formed after the 
inhibitor binds. It then takes the inhibitor ⟨𝑇𝑜𝑓𝑓
𝐸𝑆𝐼⟩ 
units of time, on average, to unbind, and for the 
enzyme another 〈𝑇𝑡𝑢𝑟𝑛
0 〉 − 〈𝑇𝑜𝑛〉 units of time to 
form a product after having just returned to the 
ES state. Here, the mean turnover time in the 
absence of inhibition, 〈𝑇𝑡𝑢𝑟𝑛
0 〉 =
1
𝑘𝑡𝑢𝑟𝑛
0 =
𝐾𝑚
𝑣𝑚𝑎𝑥
1
[𝑆]
+
1
𝑣𝑚𝑎𝑥
,   was used since inhibitor 
concentrations were assumed to be exceedingly 
low. This allows us to safely neglect the 
probability the enzyme encounters an inhibitor 
again within the remaining span of the turnover 
cycle, and one then only needs to note that the 
mean substrate binding time 〈𝑇𝑜𝑛〉 was 
subtracted from 〈𝑇𝑡𝑢𝑟𝑛
0 〉 because the reaction 
continues from the ES state rather than starts 
completely anew. In total, a product will then be 
formed, on average, after ⟨𝑇𝑟𝑒𝑚𝑎𝑖𝑛
1 ⟩ = ⟨𝑇𝑜𝑓𝑓
𝐸𝑆𝐼⟩ +
〈𝑇𝑡𝑢𝑟𝑛
0 〉 − 〈𝑇𝑜𝑛〉 units of time.  
 
Suppose now that instead of having the inhibitor 
bind the ES complex as described above, the 
reaction would have simply carried on 
uninterruptedly from that point onward, i.e., as 
it would in the absence of inhibition. How much 
time would it then take it to complete? To 
answer this, we observe that the inhibitor 
encountered the ES complex at a random point 
in time, as opposed to immediately after its 
formation. Having already spent some amount 
of time at the ES state, the mean time remaining 
before the system exits this state need not 
necessarily be identical to the mean life time, 
⟨𝑊𝐸𝑆
0 ⟩, of a freshly formed ES complex in the 
absence of inhibition. Indeed, the time we 
require here is the mean residual life time of the 
ES complex, i.e., starting from the random point 
in time at which it encountered the inhibitor and 
onward. A key result in renewal theory then 
asserts that, when averaged over all possible 
encounter times, the mean residual life time is 
given by 
1
2
⟨𝑊𝐸𝑆
0 ⟩ +
1
2
𝜎2(𝑊𝐸𝑆
0 )
⟨𝑊𝐸𝑆
0 ⟩
54, where 𝜎2(𝑊𝐸𝑆
0 ) 
denotes the variance in 𝑊𝐸𝑆
0 . This time could be 
larger, or smaller, than the mean life time 
⟨𝑊𝐸𝑆
0 ⟩, and the two are equal only when 
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𝜎2(𝑊𝐸𝑆
0 ) = ⟨𝑊𝐸𝑆
0 ⟩2—as happens, for example, 
in the case of the exponential distribution.  
 
After the system exits the ES state two things 
could happen. If a product is formed the 
reaction there ends. Otherwise, the enzyme 
reverts back to its free state, and the reaction 
takes, on average, another 〈𝑇𝑡𝑢𝑟𝑛
0 〉 units of time 
to complete. When the enzyme first enters the 
ES state the probability that a product is formed 
is Pr(𝑇𝑐𝑎𝑡 < 𝑇𝑜𝑓𝑓). What is, however, the 
probability that a product is formed from an ES 
complex that is first observed at some random 
point in time as in the scenario described above? 
Looking at the total time an enzyme spends at 
the ES state across many turnover cycles, this 
probability should coincide with the relative 
time fraction taken by ES visits which end in 
product formation, and this is given by 
Pr(𝑇𝑐𝑎𝑡 < 𝑇𝑜𝑓𝑓) ⟨𝑊𝐸𝑆
0  | 𝑇𝑐𝑎𝑡 < 𝑇𝑜𝑓𝑓⟩/⟨𝑊𝐸𝑆
0 ⟩ =
Pr(𝑇𝑐𝑎𝑡 < 𝑇𝑜𝑓𝑓) ⟨𝑊𝐸𝑆
0  | 𝐸𝑆 → 𝐸 + 𝑃⟩/⟨𝑊𝐸𝑆
0 ⟩, 
with ⟨𝑊𝐸𝑆
0  | 𝐸𝑆 → 𝐸 + 𝑃⟩ standing for the 
average time spent at the ES state given  that a 
product was formed thereafter. Summing the 
contributions above we see that when the 
reaction is left to proceed in an uninterrupted 
manner a product will be formed, on average, 
after ⟨𝑇𝑟𝑒𝑚𝑎𝑖𝑛
0 ⟩ =
1
2
⟨𝑊𝐸𝑆
0 ⟩ +
1
2
𝜎2(𝑊𝐸𝑆
0 )
⟨𝑊𝐸𝑆
0 ⟩
+
〈𝑇𝑡𝑢𝑟𝑛
0 〉(1 − Pr(𝑇𝑐𝑎𝑡 < 𝑇𝑜𝑓𝑓)⟨𝑊𝐸𝑆
0  | 𝐸𝑆 → 𝐸 +
𝑃⟩/⟨𝑊𝐸𝑆
0 ⟩)  units of time.  
 
Concluding, we observe that for the introduction 
of an inhibitor to facilitate turnover one must 
have ⟨𝑇𝑟𝑒𝑚𝑎𝑖𝑛
0 ⟩ > ⟨𝑇𝑟𝑒𝑚𝑎𝑖𝑛
1 ⟩, or equivalently  
 
⟨𝑇𝑜𝑓𝑓
𝐸𝑆𝐼⟩ < 〈𝑇𝑜𝑛〉 +
⟨𝑊𝐸𝑆
0 ⟩
2
[1 +
𝜎2(𝑊𝐸𝑆
0 )
⟨𝑊𝐸𝑆
0 ⟩
2 ] 
 
− 〈𝑇𝑡𝑢𝑟𝑛
0 〉
Pr(𝑇𝑐𝑎𝑡 < 𝑇𝑜𝑓𝑓) ⟨𝑊𝐸𝑆
0  | 𝐸𝑆 → 𝐸 + 𝑃⟩
⟨𝑊𝐸𝑆
0 ⟩
 . 
 
Recalling that 〈𝑇𝑜𝑛〉 = (𝑘𝑜𝑛[𝑆])
−1, 𝑣𝑚𝑎𝑥 =
Pr(𝑇𝑐𝑎𝑡 < 𝑇𝑜𝑓𝑓)/⟨𝑊𝐸𝑆
0 ⟩ and 𝐾𝑚 =
(𝑘𝑜𝑛⟨𝑊𝐸𝑆
0 ⟩)−1, the condition in Eq. (M5) 
(emergence of inhibitor-activator duality) can be 
rearranged and shown equivalent to  
 
 
⟨𝑇𝑜𝑓𝑓
𝐸𝑆𝐼⟩
⟨𝑊𝐸𝑆
0 ⟩
⏞
𝑟𝑎𝑡𝑖𝑜 𝑜𝑓 𝑚𝑒𝑎𝑛
𝑙𝑖𝑓𝑒 𝑡𝑖𝑚𝑒𝑠
<   
1
2
[𝐶𝑉
𝑊𝐸𝑆
0
2 − 1] 
⏞        
𝑐𝑜𝑛𝑡𝑟𝑖𝑏𝑢𝑡𝑖𝑜𝑛 𝑓𝑟𝑜𝑚 
 𝑠𝑡𝑎𝑡𝑖𝑠𝑡𝑖𝑐𝑎𝑙 𝑓𝑙𝑢𝑐𝑡𝑢𝑎𝑡𝑖𝑜𝑛𝑠 𝑖𝑛
𝑙𝑖𝑓𝑒 𝑡𝑖𝑚𝑒 𝑜𝑓 𝐸𝑆 𝑐𝑜𝑚𝑝𝑙𝑒𝑥
 
 
      +  [1 − 
⟨𝑊𝐸𝑆
0  | 𝐸𝑆→𝐸+𝑃⟩
⟨𝑊𝐸𝑆
0 ⟩
 ] 
⏞           
𝑐𝑜𝑛𝑡𝑟𝑖𝑏𝑢𝑡𝑖𝑜𝑛 𝑓𝑟𝑜𝑚 
  𝑏𝑖𝑎𝑠 𝑖𝑛 𝑏𝑟𝑒𝑎𝑘𝑑𝑜𝑤𝑛
 𝑜𝑓 𝐸𝑆 𝑐𝑜𝑚𝑝𝑙𝑒𝑥
  /   [
[𝑆]
𝐾𝑚+[S]
] 
⏞    
𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛 𝑜𝑓 𝑡𝑖𝑚𝑒
𝑠𝑝𝑒𝑛𝑡 𝑎𝑡 𝐸𝑆 
(𝑛𝑜 𝑖𝑛ℎ𝑖𝑏𝑖𝑡𝑖𝑜𝑛) 
   
. 
 
Once again, we turn attention to the fact that the 
condition in Eq. (M6) only involves means and 
variances (rather than full distributions or higher 
moments) of stochastic times associated with 
the reaction at the single molecule level, and 
that all terms in this equation are experimentally 
measurable. Equation (4) in the main text 
follows from Eq. (M6) by further assuming that 
the time for substrate unbinding is exponentially 
distributed with rate 𝑘𝑜𝑓𝑓 (SI). An alternative 
derivation of Eq. (M6) which does not really on 
probabilistic reasoning is given in the SI. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
14 
 
References  
                                                          
1 Jeremy M. Berg, John L. Tymoczko, Gregory J. Gatto, 
Lubert Stryer (2015). Biochemistry (8th ed.). San 
Francisco: W.H. Freeman. ISBN 1-4641-2610-0. 
2 David L. Nelson, Michael M. Cox (2017). Lehninger 
Principles of Biochemistry (7th ed.).  San Francisco: 
W.H. Freeman. ISBN 1-4641-2611-9.  
3 Vetter, J., 1998. Toxins of Amanita phalloides. Toxicon, 
36(1), pp.13-24. 
4 Holmes, C.F.B., Maynes, J.T., Perreault, K.R., Dawson, 
J.F. and James, M.N.G., 2002. Molecular enzymology 
underlying regulation of protein phosphatase-1 by natural 
toxins. Current medicinal chemistry, 9(22), pp.1981-1989. 
5 Poehlsgaard, J. and Douthwaite, S., 2005. The bacterial 
ribosome as a target for antibiotics. Nature Reviews 
Microbiology, 3(11), pp.870-881. 
6 Drawz, S.M. and Bonomo, R.A., 2010. Three decades of 
β-lactamase inhibitors. Clinical microbiology reviews, 
23(1), pp.160-201. 
7 Endo, A., 1992. The discovery and development of 
HMG-CoA reductase inhibitors. Journal of lipid research, 
33(11), pp.1569-1582. 
8 Wlodawer, A. and Vondrasek, J., 1998. Inhibitors of 
hiv-1 protease: A major success of structure-assisted drug 
design 1. Annual review of biophysics and biomolecular 
structure, 27(1), pp.249-284. 
9 Duke, S.O., 1990. Overview of herbicide mechanisms of 
action. Environmental health perspectives, 87, p.263. 
10 Tan, S., Evans, R. and Singh, B., 2006. Herbicidal 
inhibitors of amino acid biosynthesis and herbicide-
tolerant crops. Amino acids, 30(2), pp.195-204. 
11 House, J.E., 2007. Principles of chemical kinetics. 
Academic Press. 
12 Baici, A., 2015. Kinetics of Enzyme-Modifier 
Interactions: Selected Topics in the Theory and Diagnosis 
of Inhibition and Activation Mechanisms. Springer; and 
forward by Athel Cornish-Bowden. 
13 Claessen, V.I., Engelkamp, H., Christianen, P.C., Maan, 
J.C., Nolte, R.J., Blank, K. and Rowan, A.E., 2010. 
Single-biomolecule kinetics: the art of studying a single 
enzyme. Annual Review of Analytical Chemistry, 3, 
pp.319-340. 
14 Van Oijen, A.M., 2011. Single-molecule approaches to 
characterizing kinetics of biomolecular interactions. 
Current opinion in biotechnology, 22(1), pp.75-80. 
15 Funatsu, T., Harada, Y., Tokunaga, M., Saito, K. and 
Yanagida, T., 1995. Imaging of single fluorescent 
molecules and individual ATP turnovers by single myosin 
molecules in aqueous solution. Nature 374, pp. 555 – 559.  
16 Lu, H.P., Xun, L. and Xie, X.S., 1998. Single-molecule 
enzymatic dynamics. Science, 282(5395), pp.1877-1882. 
17 Edman, L. and Rigler, R., 2000. Memory landscapes of 
single-enzyme molecules. Proceedings of the National 
Academy of Sciences, 97(15), pp.8266-8271. 
                                                                                              
18 Flomenbom, O., Velonia, K., Loos, D., Masuo, S., 
Cotlet, M., Engelborghs, Y., Hofkens, J., Rowan, A.E., 
Nolte, R.J., Van der Auweraer, M. and de Schryver, F.C., 
2005. Stretched exponential decay and correlations in the 
catalytic activity of fluctuating single lipase molecules. 
Proceedings of the National Academy of Sciences of the 
United States of America, 102(7), pp.2368-2372. 
19 English, B.P., Min, W., Van Oijen, A.M., Lee, K.T., 
Luo, G., Sun, H., Cherayil, B.J., Kou, S.C. and Xie, X.S., 
2006. Ever-fluctuating single enzyme molecules: 
Michaelis-Menten equation revisited. Nature chemical 
biology, 2(2), pp.87-94. 
20 Lerch, H.P., Mikhailov, A.S. and Hess, B., 2002. 
Conformational-relaxation models of single-enzyme 
kinetics. Proceedings of the National Academy of 
Sciences, 99(24), pp.15410-15415. 
21 Min, W., Gopich, I.V., English, B.P., Kou, S.C., Xie, 
X.S. and Szabo, A., 2006. When does the Michaelis-
Menten equation hold for fluctuating enzymes? The 
Journal of Physical Chemistry B, 110(41), pp.20093-
20097. 
22 Moffitt, J.R., Chemla, Y.R. and Bustamante, C., 2010. 
Mechanistic constraints from the substrate concentration 
dependence of enzymatic fluctuations. Proceedings of the 
National Academy of Sciences, 107(36), pp.15739-15744. 
23 Wu, J. and Cao, J., 2011. Generalized Michaelis–
Menten Equation for Conformation‐Modulated 
Monomeric Enzymes. Single-Molecule Biophysics: 
Experiment and Theory, Volume 146, pp.329-365. 
24 Chaudhury, S., Cao, J. and Sinitsyn, N.A., 2013. 
Universality of Poisson indicator and Fano factor of 
transport event statistics in ion channels and enzyme 
kinetics. The Journal of Physical Chemistry B, 117(2), 
pp.503-509.  
25 Moffitt, J.R. and Bustamante, C., 2014. Extracting 
signal from noise: kinetic mechanisms from a Michaelis–
Menten‐like expression for enzymatic fluctuations. FEBS 
Journal, 281(2), pp.498-517. 
26 Barato, A. C. and Seifert, U. Skewness and kurtosis in 
statistical kinetics, Phys. Rev. Letters, (2015) 115, 
188103. 
27 Barato, A. C., and Seifert, U. Universal bound on the 
Fano factor in enzyme kinetics, J. Phys. Chem. B (2015) 
119, 6555−6561. 
28 Wiita, A.P., Perez-Jimenez, R., Walther, K.A., Gräter, 
F., Berne, B.J., Holmgren, A., Sanchez-Ruiz, J.M. and 
Fernandez, J.M., 2007. Probing the chemistry of 
thioredoxin catalysis with force. Nature, 450(7166), 
pp.124-127.  
29 Lomholt MA, Urbakh M, Metzler R, Klafter J (2007) 
Manipulating single enzymes by an external harmonic 
force. Phys Rev Lett 98(16):168302. 
30 Gumpp, H., Puchner, E.M., Zimmermann, J.L., 
Gerland, U., Gaub, H.E. and Blank, K., 2009. Triggering 
15 
 
                                                                                              
enzymatic activity with force. Nano letters, 9(9), pp.3290-
3295.  
31 Alegre-Cebollada, J., Perez-Jimenez, R., Kosuri, P. and 
Fernandez, J.M., 2010. Single-molecule force 
spectroscopy approach to enzyme catalysis. Journal of 
Biological Chemistry, 285(25), pp.18961-18966. 
32 Puchner, E.M. and Gaub, H.E., 2012. Single-molecule 
mechanoenzymatics. Annual review of biophysics, 41, 
pp.497-518. 
33 Gorris, H.H., Rissin, D.M. and Walt, D.R., 2007. 
Stochastic inhibitor release and binding from single-
enzyme molecules. Proceedings of the National Academy 
of Sciences, 104(45), pp.17680-17685. 
34 Piwonski, H.M., Goomanovsky, M., Bensimon, D., 
Horovitz, A. and Haran, G., 2012. Allosteric inhibition of 
individual enzyme molecules trapped in lipid vesicles. 
Proceedings of the National Academy of Sciences, 
109(22), pp.E1437-E1443. 
35 Chaudhury, S.Poisson indicator and fano factor for 
probing dynamic disorder in single-molecule enzyme 
inhibition kinetics, J. Phys. Chem. B (2014) 118, 
10405−10412. 
36 Saha, S., Sinha, A. and Dua, A., 2012. Single-molecule 
enzyme kinetics in the presence of inhibitors. The Journal 
of chemical physics, 137(4), p.045102. 
37 Pelz, B., Žoldák, G., Zeller, F., Zacharias, M. and Rief, 
M., 2016. Subnanometre enzyme mechanics probed by 
single-molecule force spectroscopy. Nature 
communications, 7. 
38 Reuveni, S., Urbakh, M. and Klafter, J., 2014. Role of 
substrate unbinding in Michaelis–Menten enzymatic 
reactions. Proceedings of the National Academy of 
Sciences, 111(12), pp.4391-4396. 
39 Rotbart, T., Reuveni, S. and Urbakh, M., 2015. 
Michaelis-Menten reaction scheme as a unified approach 
towards the optimal restart problem. Physical Review E, 
92(6), p.060101. 
40 Reuveni, S., 2016. Optimal stochastic restart renders 
fluctuations in first passage times universal. Physical 
review letters, 116(17), p.170601. 
41 Pal, A. and Reuveni, S., 2017. First Passage under 
Restart. Physical Review Letters, 118(3), p.030603.  
42 Bar-Even, A., Noor, E., Savir, Y., Liebermeister, W., 
Davidi, D., Tawfik, D.S. and Milo, R., 2011. The 
moderately efficient enzyme: evolutionary and 
physicochemical trends shaping enzyme parameters. 
Biochemistry, 50(21), pp.4402-4410. 
43 Lineweaver, H. and Burk, D., 1934. The determination 
of enzyme dissociation constants. Journal of the American 
Chemical Society, 56(3), pp.658-666.  
44 In this sense, the approach presented in this paper could 
be said to be semi-Markovian. 
45 Schenker, P. and Baici, A., 2009. Simultaneous 
interaction of enzymes with two modifiers: reappraisal of 
                                                                                              
kinetic models and new paradigms. Journal of theoretical 
biology, 261(2), pp.318-329. 
46 Schenker, P. and Baici, A., 2010. Paradoxical 
interactions between modifiers and elastase‐2. The FEBS 
journal, 277(11), pp.2486-2495. 
47 Lanz, T.A., Karmilowicz, M.J., Wood, K.M., 
Pozdnyakov, N., Du, P., Piotrowski, M.A., Brown, T.M., 
Nolan, C.E., Richter, K.E., Finley, J.E. and Fei, Q., 2006. 
Concentration-dependent modulation of amyloid-β in 
vivo and in vitro using the γ-secretase inhibitor, LY-
450139. Journal of Pharmacology and Experimental 
Therapeutics, 319(2), pp.924-933. 
48 Burton, C.R., Meredith, J.E., Barten, D.M., Goldstein, 
M.E., Krause, C.M., Kieras, C.J., Sisk, L., Iben, L.G., 
Polson, C., Thompson, M.W. and Lin, X.A., 2008. The 
amyloid-β rise and γ-secretase inhibitor potency depend 
on the level of substrate expression. Journal of Biological 
Chemistry, 283(34), pp.22992-23003. 
49 Svedružić, Ž.M., Popović, K. and Šendula-Jengić, V., 
2013. Modulators of γ-secretase activity can facilitate the 
toxic side-effects and pathogenesis of Alzheimer's 
disease. PloS one, 8(1), p.e50759. 
50 Walsh, R., 2014. Are improper kinetic models 
hampering drug development? PeerJ, 2, p.e649. 
51 Al-Shawi, M.K., Polar, M.K., Omote, H. and Figler, 
R.A., 2003. Transition state analysis of the coupling of 
drug transport to ATP hydrolysis by P-
glycoprotein. Journal of Biological Chemistry, 278(52), 
pp.52629-52640. 
52 Omote, H. and Al-Shawi, M.K., 2002. A novel electron 
paramagnetic resonance approach to determine the 
mechanism of drug transport by P-glycoprotein. Journal 
of Biological Chemistry, 277(47), pp.45688-45694. 
53 Horovitz, A., Fridmann, Y., Kafri, G. and Yifrach, O., 
2001. Allostery in chaperonins. Journal of Structural 
Biology, 135(2), pp.104-114. 
54 Gallager, R.G., 2013. Stochastic processes: theory for 
applications. Cambridge University Press. 
 
 
